James F. Howard, MD

Distinguished Professor of Neuromuscular Disease; professor of neurology and medicine, University of North Carolina School of Medicine

Articles

ADAPT Trial of Efgartigimod and its Potential in gMG: James F. Howard, MD

June 16, 2021

The Distinguished Professor of Neuromuscular Disease at UNC School of Medicine discussed the findings of the ADAPT trial and the promise efgartigimod has shown to be an effective agent for generalized myasthenia gravis.